Absolutely, the Journal of the American Pharmacists Association (JAPhA) aims to be the bridge between science and practice in the field of pharmacy. It focuses on publishing top-notch empirical studies, comprehensive reviews, and thought-provoking opinion pieces with the overarching goal of optimizing medication use to enhance both individual patient and broader population health outcomes.
Focus and Scope
JAPhA welcomes submissions that offer insights into advancing pharmacy practice across various settings—be it a community pharmacy, a hospital, or specialized healthcare centers. The journal is particularly interested in submissions that contribute to optimizing medication usage, enhancing pharmacotherapy, and promoting public health globally.
Topics of interest include but are not limited to:
- Development and evaluation of innovative pharmacy services or models of care
- Medication use studies
- Interventions to improve medication use
- Advances in pharmacotherapy, particularly as reviews
- Health outcomes research
- Pharmacoepidemiology
- Pharmacoeconomics
- Health services research
- Evaluations of drug benefit designs
- Healthcare policy formulation and evaluation
- Implementation science
- Patient-reported outcomes and preferences
- Education of pharmacy professionals, including continuing professional development
- Workforce issues, well-being, reimbursement, and other matters affecting pharmacy as a profession
- The application of new technologies in healthcare
- Research methods specifically applicable to pharmacy practice
- Advocacy, legal, and regulatory issues concerning pharmacy and healthcare
Exclusions
It’s important to note that JAPhA typically will not consider submissions that are purely focused on pharmacokinetic or pharmacodynamic studies unless they have a direct application in practice. Studies involving animal models or those restricted to in vitro or in silico research are also generally excluded. While the journal is open to educational scholarship, articles solely focusing on the pharmacy curriculum are generally not considered, unless there is a clear relevance to practical pharmacy operations.
Objective
The guidelines and focus areas serve to maintain the rigorous quality of the journal. JAPhA aims to be an essential read for pharmacists, healthcare professionals, policy-makers, and researchers who are interested in the latest empirical evidence and viewpoints that have the potential to shape the future of pharmacy practice and healthcare.
In summary, JAPhA serves as a crucial platform for the exchange of ideas and findings that have the potential to impact pharmacy practice positively and thereby contribute to improving public health outcomes.
Volume 62, Issue 1: Pages 1-386 (January–February 2022)
Volume 62, Issue 2: Pages 387-638 (March–April 2022)
Volume 62, Issue 3: Pages 639-902 (May–June 2022)
Volume 62, Issue 4: Pages 903-1450 (July–August 2022)
Volume 62, Issue 5: Pages 1451-1716 (September–October 2022)
Volume 62, Issue 6: Pages 1717-1946 (November–December 2022)
Volume 63, Issue 1: Pages A1-A8, 1-446 (January–February 2023)
Volume 63, Issue 2: Pages A1-A6, 447-700 (March–April 2023)
Volume 63, Issue 3: Pages A1-A6, 701-980 (May–June 2023)
Volume 63, Issue 4, Supplement: Pages A1-A6, S1-S106 (July–August 2023)
Volume 63, Issue 4: Pages A1-A6, 983-1442 (July–August 2023)
Volume 63, Issue 5: Pages A1-A6, 1443-1652 (September–October 2023)
Volume 63, Issue 6: Pages A1-A6, 1653-1838 (November–December 2023)
Volume 64, Issue 1: Pages A1-A6, e3-e4, 1-2 (January–February 2024)
Volume 64, Issue 2: Pages A1-A6, 321-596 (March–April 2024)
Volume 64, Issue 3: May–June 2024
Volume 64, Issue 4: July–August 2024
Volume 64, Issue 5: September–October 2024